Stimulants
MethylphenidateMethylphenidate Hydrochloride
Methylphenidate is a stimulant sold as Ritalin tablets, Methylin solution and generics, and in extended-release forms such as Concerta, Ritalin LA, Jornay PM and the Daytrana patch. All are labeled for ADHD, and the short-acting tablets and solution also for narcolepsy. It is Schedule II, carries a boxed warning about abuse, misuse and addiction, and its forms are not interchangeable.
This page is general information about a medication and how cash prices for it are set. It is not medical advice and does not replace the label, your prescriber or your pharmacist. How we handle medical information
Every brand listed here except Jornay PM, QuilliChew ER and Relexxii has generics, each rated only to its own brand. Adhansia XR, Ritalin-SR and Methylin chewable tablets are discontinued.
About Methylphenidate
Methylphenidate blocks the reuptake of norepinephrine and dopamine and increases their release; how this helps ADHD is not known. Ritalin tablets and Methylin solution are labeled for ADHD in adults and children 6 and older and for narcolepsy: children start at 5 mg twice a day, before breakfast and lunch, adults usually take 20 to 30 mg a day in two or three doses, and more than 60 mg a day is not recommended. Extended-release brands are labeled for ADHD only, with label-specific ages, such as 6 to 65 for Concerta, 6 to 12 for Ritalin LA, 6 to 15 for Metadate CD and 6 to 17 for Cotempla XR-ODT and Daytrana.
The boxed warning says it has a high potential for abuse and misuse, which can lead to a substance use disorder, including addiction, and to overdose and death, a risk raised by higher doses or unapproved routes; prescribers assess each patient’s risk before and during treatment and teach safe storage and disposal. It must not be taken with, or within 14 days of, an MAO inhibitor, or by anyone allergic to it. Other warnings cover sudden death in serious heart disease, raised blood pressure and heart rate, psychotic or manic symptoms, prolonged erections, poor circulation in the fingers and toes, slowed growth in children, glaucoma and tics; Concerta, a tablet that keeps its shape, is not ordinarily used in severe narrowing of the gut. A fast heartbeat, headache, trouble sleeping, anxiety, decreased appetite, weight loss and stomach pain are common.
As a Schedule II drug it cannot be refilled; each fill needs a new prescription. With the Daytrana patch, external heat raises absorption, and skin at the site can lose its color, sometimes lastingly. Since a 2025 FDA safety communication, extended-release labels advise against use under age 6, as children that young had higher drug levels and more side effects, such as weight loss. In pregnancy, published data have not shown a drug-associated risk of major birth defects or miscarriage, though stimulants may carry fetal risks; a breastfed baby is watched for agitation, poor sleep, poor appetite and slow weight gain. In October 2026 the FDA shortage list showed the extended-release tablets (posted July 2023) and the patch (posted February 2025) as currently in shortage.
Taking Methylphenidate
- How to take it
- Tablets and solution: usually two or three times a day before meals, with an adult’s last dose before 6 p.m. if late doses disturb sleep. Swallow Concerta and Relexxii whole; let Cotempla XR-ODT dissolve on the tongue; Ritalin LA, Metadate CD, Aptensio XR and Jornay PM (taken in the evening) capsules may be opened onto applesauce. Daytrana goes on the hip 2 hours before the effect is needed and comes off 9 hours later, or sooner if advised.
- If you miss a dose
- Take it when you remember unless the next dose is almost due, then skip it; ask how late in the day is too late. Jornay PM: take it that evening, or skip it if it is already morning. Never take a double dose.
- Storage
- At room temperature, tightly closed, away from light, heat and moisture, in a safe place (preferably locked). Do not flush tablets or capsules; use a take-back program.
- Interactions to know about
- Never with or within 14 days of an MAO inhibitor, such as linezolid or methylene blue. It can weaken blood pressure medicines and is avoided on the day of surgery with halogenated anesthetics; with risperidone, a dose change of either can bring on movement side effects.
This summarizes the official prescribing information. Your prescriber’s and pharmacist’s instructions, and the leaflet that comes with your medicine, take priority.
Why the cash price for Methylphenidate differs from pharmacy to pharmacy
Each form is a separate product: a pharmacist can substitute only a generic rated to the product written, so a Ritalin LA generic cannot fill a Metadate CD prescription, and Jornay PM, QuilliChew ER and Relexxii have no rated generic. Each pharmacy sets its own cash price, including its dispensing fee.
If a pharmacy can supply only part of the quantity, the rest can follow within 72 hours; after that a new prescription is needed.
Upload it and licensed pharmacies reply with their own cash price. You pay the pharmacy, not us.
Ways to pay less for Methylphenidate without insurance
- Ask the prescriber to allow generic substitution rather than naming a brand only.
- Confirm the pharmacy has your product and strength before the prescription is sent; an unfilled electronic prescription can be transferred only once.
- Ask for a partial fill if you want fewer at first; where state law allows, the rest can follow within 30 days of the date written.
- For Jornay PM or QuilliChew ER, ask the maker whether a savings program applies to someone paying cash.
- Upload the prescription to Script Unlock so licensed pharmacies can quote their cash price. You pay the pharmacy directly.
How Script Unlock gets you a cash price for Methylphenidate
Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.
- 1You upload your prescription
A photo of your Methylphenidate prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.
- 2Licensed pharmacies respond
Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.
- 3You choose and pay the pharmacy
You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.
Questions to ask your pharmacist about Methylphenidate
- 1.Can you fill my exact product, strength and full quantity?
- 2.Is the generic you would give me rated equivalent to my brand?
- 3.Is it safe with my blood pressure medicine, risperidone or antidepressant?
Where Methylphenidate fits
Refill, transfer and electronic-prescribing rules for controlled substances differ by state. See pharmacy rules by state.
Related medications
Sources
- FDA-approved labeling on DailyMed (methylphenidate)
- MedlinePlus drug information (National Library of Medicine)
- FDA Orange Book (approved generics and therapeutic equivalence)
- MedlinePlus, methylphenidate
- Concerta (methylphenidate HCl) extended-release tablets prescribing information, revised April 2026 (Drugs@FDA)
- Ritalin (methylphenidate HCl) tablets prescribing information, revised February 2025 (Drugs@FDA)
- Daytrana (methylphenidate transdermal system) prescribing information, revised September 2025 (Drugs@FDA)
- Jornay PM (methylphenidate HCl) extended-release capsules prescribing information, revised September 2025 (Drugs@FDA)
- Drugs@FDA, Ritalin (NDA 010187): generic tablets rated AB
- Drugs@FDA, Methylin oral solution (NDA 021419): generics rated AA
- Drugs@FDA, Concerta (NDA 021121): generic extended-release tablets rated AB
- Drugs@FDA, Relexxii (NDA 216117): approved 2022, equivalence rating to be determined
- Drugs@FDA, Ritalin LA (NDA 021284): generics rated AB1; 60 mg discontinued; label revised September 2025
- Drugs@FDA, Metadate CD (NDA 021259): generics rated AB2; label revised September 2025
- Drugs@FDA, Aptensio XR (NDA 205831): generic rated AB3; label revised September 2025
- Drugs@FDA, Jornay PM (NDA 209311): no therapeutic equivalent
- Drugs@FDA, QuilliChew ER (NDA 207960): no therapeutic equivalent
- Drugs@FDA, Cotempla XR-ODT (NDA 205489): generic rated AB; label revised September 2025
- Drugs@FDA, Quillivant XR (NDA 202100): generic rated AB
- Drugs@FDA, Daytrana (NDA 021514): generic rated AB
- Drugs@FDA, Adhansia XR (NDA 212038): all strengths discontinued
- Drugs@FDA, Methylin chewable tablets (NDA 021475): all strengths discontinued
- Drugs@FDA, Ritalin-SR (NDA 018029): discontinued
- FDA Drug Shortages, methylphenidate hydrochloride extended-release tablets (currently in shortage, first posted July 2023)
- FDA Drug Shortages, methylphenidate extended-release film (patch) (currently in shortage, first posted February 2025)
- FDA, required updates to the labeling of prescription stimulants used to treat ADHD (May 2023)
- FDA Drug Safety Communication, expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants (June 2025)
- Code of Federal Regulations, 21 CFR part 1306 (prescriptions)
Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.